Advertisement
Screener

OncoMed Pharmaceuticals Inc Interest Expense

OncoMed Pharmaceuticals Inc Interest Expense

OncoMed Pharmaceuticals Inc reported Interest Expense of $6.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-18.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2014-03-18

  • OncoMed Pharmaceuticals Inc interest expense for the quarter ending 2012-06-30 was $1.00K.
  • OncoMed Pharmaceuticals Inc interest expense for fiscal 2012 was $6.00K, a 84.21% decline from fiscal 2011.
  • OncoMed Pharmaceuticals Inc interest expense for fiscal 2011 was $38.00K.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 12 month
2012-12-31$6.00K
10-K · filed 2014-03-18
2012-06-30$1.00K
10-Q · filed 2013-09-03
$6.00K
10-Q · filed 2013-09-03
2011-12-31$38.00K
10-K · filed 2014-03-18